(19)
(11) EP 1 741 716 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
22.02.2012 Bulletin 2012/08

(45) Mention of the grant of the patent:
28.09.2011 Bulletin 2011/39

(21) Application number: 05737233.6

(22) Date of filing: 27.04.2005
(51) International Patent Classification (IPC): 
C07D 493/04(2006.01)
A61P 35/00(2006.01)
 A61K 31/443(2006.01)
C07D 213/61(2006.01)
(86) International application number:
PCT/JP2005/008034
(87) International publication number:
WO 2005/105807 (10.11.2005 Gazette 2005/45)

(54)

PROCESS FOR PRODUCING PENTACYCLIC TAXANE

VERFAHREN ZUR HERSTELLUNG VON PENTACYCLISCHEM TAXAN

PROCESSUS DE PRODUCTION DE TAXANE PENTACYLIQUE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 30.04.2004 JP 2004136359

(43) Date of publication of application:
10.01.2007 Bulletin 2007/02

(73) Proprietor: Daiichi Sankyo Company, Limited
Chuo-ku Tokyo (JP)

(72) Inventors:
  • IMURA, Akihiro, DAIICHI PHARMACEUTICAL CO., LTD.
    Tokyo 134-8630 (JP)
  • YAMAGUCHI, Tatsuya, DAIICHI PHARMACEUTICAL CO.,Ltd
    Tokyo 134-8630 (JP)
  • TAKAYANAGI, Y., DAIICHI PHARMACEUTICAL Co., Ltd.
    Tokyo 134-8630 (JP)
  • UCHIDA, Seishiro, DAIICHI PHARMACEUTICAL CO., Ltd.
    Tokyo 134-8630 (JP)

(74) Representative: Reitstötter - Kinzebach 
Patentanwälte Sternwartstrasse 4
81679 München
81679 München (DE)


(56) References cited: : 
EP-A- 1 221 445
WO-A1-01/27115
JP-A- 2002 332 287
 EP-A1- 0 826 688
JP-A- 9 012 578
US-A1- 2002 143 178
   
  • TAKEDA, YASUYUKI ET AL: "New highly active taxoids from 9.beta.-Dihydrobaccatin-9,10-acetals. Part 4" BIOORGANIC & MEDICINAL CHEMISTRY , 11(20), 4431-4447 CODEN: BMECEP; ISSN: 0968-0896, 2003, XP002990390
  • TAKEDA Y. ET AL: 'New highly active taxoids from 9 beta-Dihydrobaccatin-9,10-acetals.' BIOORGANIC & MEDICINAL CHEMISTRY. vol. 11, no. 20, 2003, pages 4431 - 4447, XP002990390
  • BOLSTER M. ET AL: 'The synthesis of Ambox-like compounds starting from (+)-larixol. Part 2.' TETRAHEDRON. vol. 57, no. 39, 2001, pages 8369 - 8379, XP004305842
  • BOLSTER M.G. ET AL: 'The synthesis of Ambrox-like compounds starting from(+)-larixol.' TETRAHEDRON. vol. 57, no. 26, 2001, pages 5663 - 5679, XP004247105
  • BISCHOFBERGER N. ET AL: 'Synthesis of analogs of 1,3-dehydroxyacetone phosphate and glyceraldehyde 3-phosphate for use in studies in fructose-1,6-diphosphate aldolase.' JOURNAL OF ORGANIC CHEMISTRY. vol. 53, no. 15, 1988, pages 3457 - 3465, XP000994868
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).